Journal of Proteome ResearchSystems BiologyPeer-reviewed journal article
Deep time course proteomics of SARS-CoV and SARS-CoV-2-infected human lung epithelial cells (Calu-3) reveals strong induction of interferon-stimulated gene (ISG) expression by SARS-CoV-2 in contrast to SARS-CoV
Marica GrossegesseiD, Daniel R. BourquainiD, Markus NeumanniD, Lars SchaadeiD, Jessica SchulzeiD, Christin Mache, Thorsten WolffiD, Andreas NitscheiD, Joerg DoellingeriD
Abstract
SARS-CoV and SARS-CoV-2 infections are characterized by remarkable differences, including contagiosity and case fatality rate. The underlying mechanisms are not well understood, illustrating major knowledge gaps of coronavirus biology. In this study, protein expression of SARS-CoV- and SARS-CoV-2-infected human lung epithelial cell line Calu-3 was analysed using data-independent acquisition mass spectrometry (DIA-MS). This resulted in the so far most comprehensive map of infection-related proteome-wide expression changes in human cells covering the quantification of 7478 proteins across 4 time points. Most notably, the activation of interferon type-I response was observed, which surprisingly is absent in other recent proteome studies, but is known to occur in SARS-CoV-2-infected patients. The data reveal that SARS-CoV-2 triggers interferon-stimulated gene (ISG) expression much stronger than SARS-CoV, which reflects the already described differences in interferon sensitivity. Potentially, this may be caused by the enhanced expression of viral M protein of SARS-CoV in comparison to SARS-CoV-2, which is a known inhibitor of type I interferon expression. This study expands the knowledge on the host response to SARS-CoV-2 infections on a global scale using an infection model, which seems to be well suited to analyse innate immunity.
- organism: human
- assay: proteomics
- research focus: differential expression
- research focus: benchmarking
- approach: statistical model
- Citations
- 22
- FWCI
- 2.32
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses
A. Banerjee, N. El-Sayes, … K. Mossman·bioRxiv·Jun 18, 2020
- Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
- Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
K. G. Lokugamage, A. Hage, … V. D. Menachery·Journal of VirologyPeer-reviewed·Nov 9, 2020
- Tropism of SARS-CoV-2 in commonly used laboratory cell lines and their proteomic landscape during infection
- Type I and Type III IFN Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures
A. Vanderheiden, P. Ralfs, … M. S. Suthar·bioRxiv·May 19, 2020
- Type I interferon signaling induces a delayed antiproliferative response in Calu-3 cells during SARS-CoV-2 infection
J. B. Cunha, K. Leix, … B. T. Emmer·bioRxiv·Feb 28, 2023